Insomnia treatment is restructured Psychology today

Bootzin, RR (1972). Treating stimulation to treat insomnia. The facts of the American Psychological Association, 7395-396.

Kripke, DF, Langer, RD, & Kline, Le (2012). Longing to death or cancer: studying identical dust. BMJ Open, 2(1), e000850. https://pubmed.ncbi.nlm.nih.gov/22371848/

Morin, CM, Colecchi, C., Stone, J., SOID, R., & Brink, D. (1999). Behavioral and pharmaceutical treatments of insomnia of life: a random experience governed. Mosque, 281(11), 991-999. https://doi.org/10.1001/jama.281.11.991

Morin, CM, Vallières, A., Guay, B., IVERS, H., Savard, J., Mérette, C., … & Bailageon, L. (2009). Cognitive behavioral therapy, individually and integrated with medications, for persistent insomnia: a random experiment governed. Gama, 301(19), 2005-2015. https://doi.org/10.1001/jama.2009.682

Morin, CM, Bastien, C., Guay, B., Radouco-thomas, M., Leblanc, J., & Vallières, A. (2004). A random clinical trial for undergoing treatment and cognitive behavioral therapy to facilitate the interruption of benzodiazepine in older adults who suffer from chronic insomnia. The American Psychiatry Journal, 161(2), 332-342.

National Institutes of Health. (2005). Statement of the National Institutes of Health on manifestations and the management of chronic insomnia for adults, 13-15 June 2005. NIH ConSES State Sci Dities, 22(2), 1-30.

Qaseeem, A., Kansagara, D., Forciea, MA, Cooke, M., & Denberg, TD (2016). Adult’s chronic insomnia disorder management: guidelines for clinical practice from the American College of Doctors. Annals of internal medicine, 165(2), 125-133. https://doi.org/10.7326/m15-2175

Sateia, MJ, Buysse, DJ, Krystal, AD, Neubauer, DN, & Heald, JL (2017). The guideline of the clinical practice of drug therapy for chronic insomnia in adults: guidance for the American Academy of Clinical Sleep Medicine. Clinical sleep medicine magazine, 13(2), 307-349. https://doi.org/10.5664/jcsm.6470

Spielman, AJ, Saskin, P., & Thorpy, MJ (1987). Treating chronic insomnia by restricting time in bed. Sleep, 10(1), 45-56. https://doi.org/10.1093/sleep/10.1.45

American Food and Drug Administration. (2013). Drug safety contacts in the Food and Drug Administration (FDA): the risk of developing the next morning after the use of insomnia drugs; Food and Drug Administration requires less recommended doses for some drugs that contain zolpidem (Ambien, ABIEN CR, Edluar, and Zolpimist). https://www.fda.gov/drugs/drug-safty-and-vailaving

American Food and Drug Administration. (2019). The Food and Drug Administration adds a warning to the risk of serious injuries caused by sleeping, and sleeping and participating in other activities while not waking up completely when taking some medicinal prescription medications. https://www.fda.gov/drugs/drug-safty-and-vailaving